ScholarIQanswers from OpenAlex

Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy

PaperCitations, authors & open-access status

Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy have?

ScholarIQcitation count

Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy has 138 citations in the OpenAlex counts ScholarIQ stores.

When was Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy published?

ScholarIQyear

Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy has 2014 year in the ScholarIQ index.

What is the open-access status of Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy?

ScholarIQoa status

Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy has bronze oa status in the ScholarIQ index.

What is the DOI of Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy?

ScholarIQdoi

The DOI for Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy is on the source record.

What is the PMID of Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy?

ScholarIQpmid

The PMID for Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy is on the source record.

What is the OpenAlex record for Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy?

ScholarIQopenalex

The OpenAlex for Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial